09:00-10:30 |
OPERATIVE OBSTETRICS AND LITIGATION |
Capsule | Can better understanding decrease litigation? |
Chairpersons | Aris Antsaklis, Greece Frank Chervenak, USA Zoltán Papp, Hungary |
09:00-09:20 | Odone: Can it replace all surgical deliveries? Gian Carlo Di Renzo, Italy |
09:20-09:45 | Litigation; Scope of the problem Dan Farine, Canada |
09:45-10:05 | Are the criteria for the association between perinatal events and brain damage valid? Isaac Blickstein, Israel |
10:05-10:30 | Already brain damaged upon admission: Can we diagnose? Dan Farine, Canada |
10:50-12:20
|
FETAL MONITORING: QUO VADIS |
Capsule | Fetal monitoring remains controversial despite years of use and computerized improvements. Where do we come from? Where are we going? Can we do without it or keep improving the technique? |
Chairpersons | Gerard H.A. Visser, The Netherlands Istvan Sziller, Hungary |
10:50-11:20 | Processing of FHR rate: Does it offer an advantage? Diogo Ayres de Campos, Portugal |
11:20-11:50 | The limitations of FHR Tim Van Mighem, Belgium |
11:50-12:20 | The new FIGO guidelines on FHR monitoring Diogo Ayres de Campos, Portugal |
12:30-14:00
|
FETAL MONITORING |
Capsule | Should we be satisfied with what we have or maybe strive to have better methods? |
Chairpersons | Isaac Blickstein, Israel Diogo Ayres de Campos, Portugal Zoran Belics, Hungary |
12:30-13:00 | Auscultation vs. FHR Dan Farine, Canada |
13:00-13:30 | FHR: Why is it not enough? Diogo Ayres de Campos, Portugal |
13:30-14:00 | Intrapartum fetal monitoring is a risky business for both fetus and doctor Gerard H.A. Visser, The Netherlands |
14:50-16:20 |
PROGESTERONE SUPPORT DURING PREGNANCY |
Capsule | Progesterone seems to be very effective in preventing PTL and pregnancy loss |
Chairpersons | Frank Chervenak, USA Mattheos Fraidakis, Greece |
14:50-15:10 | Progesterone treatment for PTL Natasha Hezelgrave, UK |
15:10-15:35 | Is progesterone effective in multiple pregnancies? Isaac Blickstein, Israel |
15:35-15:55 | Progesterone - what is new? Dan Farine, Canada |
15:55-16:20 |
Efficacy of progesterone support in recurrent pregnancy loss |
16:40-18:10
|
PRENATAL DIAGNOSIS IN THE ERA OF NIPT |
Capsule | Non-invasive prenatal testing (NIPT) is expanding rapidly beyond the high risk pregnancy population, will it ever replace ll invasive testing? |
Chairpersons | Christian Dadak, Austria Gyula Richard Nagy, Hungary |
16:40-17:05 | The scientific basis for NIPT Patricia Devers Winters, USA |
17:05-17:25 | What the clinician should know about incorporating NIPT in the practice Nan Okun, Canada |
17:25-17:50 | The clinical evolution of NIPT: Past, present, and future Patricia Devers Winters, USA |
17:50-18:10 | Will NIPT amniocentesis and CVS disappear from the routine practice? Nan Okun, Canada |
09:00-10:30
|
CONTROVERSIES IN PATIENT SAFETY |
Chairpersons | Isaac Blickstein, Israel Nan Okun, Canada Milan Terzic, Serbia |
09:00-09:30 | Improvements in patient safety: A necessary achievable goal in obstetrics today Frank A. Chervenak, USA |
09:30-10:00 | Controversies in the management of shoulder dystocia Christian Dadak, Austria |
10:00-10:30 | The WHO claims that CS is above the optimal CS rate and should be decreased. Isn’t it too late for this battle? Michael Robson, Ireland |
10:50-12:20
|
OBESITY IN PREGNANCY |
Capsule | Obesity was declared an epidemic, obstetric complications are now being recognized, what are the implications? |
Chairperson | Aris Antsaklis, Greece |
10:50-11:15 | Are the recommended guidelines for weight gain during pregnancy realistic? Isaac Blickstein, Israel |
11:15-11:35 | Maternal issues Natasa Tul-Mandić, Slovenia |
11:35-12:00 | Labor management Dan Farine, Canada |
12:00-12:20 | Encouraging weight loss and optimal weight pre-conception Gerard H.A. Visser, The Netherlands |
12:30-14:00 |
FETAL GROWTH |
Chairpersons |
Natasa Tul-Mandić, Slovenia |
12:30-13:00 |
What is the optimal fetal growth? |
13:00-13:30 |
The use of Doppler ultrasound in managing IUGR |
13:30-14:00 |
Should we supplement magnesium in pregnancy? |
14:50-16:20 |
MECHANICAL PROBLEMS |
|
Chairperson |
Michael Robson, Ireland |
|
14:50-15:50 14:50-15:10 15:10-15:30 15:30-15:50 |
|
|
15:50-16:20 | Vacuum vs. forceps Tim Van Mieghem, Belgium |
16:40-18:10 |
Round Table Discussion
|
Moderators |
Dan Farine, Canada
|
Panelists |
Gerard H.A. Visser, The Netherlands |
Questions |
1. Uterine septum: Should be excised in nulligravida? |